These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

714 related items for PubMed ID: 11948118

  • 1. Silencing of GSTP1 gene by CpG island DNA hypermethylation in HBV-associated hepatocellular carcinomas.
    Zhong S, Tang MW, Yeo W, Liu C, Lo YM, Johnson PJ.
    Clin Cancer Res; 2002 Apr; 8(4):1087-92. PubMed ID: 11948118
    [Abstract] [Full Text] [Related]

  • 2. GSTP1 CpG island DNA hypermethylation in hepatocellular carcinomas.
    Tchou JC, Lin X, Freije D, Isaacs WB, Brooks JD, Rashid A, De Marzo AM, Kanai Y, Hirohashi S, Nelson WG.
    Int J Oncol; 2000 Apr; 16(4):663-76. PubMed ID: 10717233
    [Abstract] [Full Text] [Related]

  • 3. Reversal of GSTP1 CpG island hypermethylation and reactivation of pi-class glutathione S-transferase (GSTP1) expression in human prostate cancer cells by treatment with procainamide.
    Lin X, Asgari K, Putzi MJ, Gage WR, Yu X, Cornblatt BS, Kumar A, Piantadosi S, DeWeese TL, De Marzo AM, Nelson WG.
    Cancer Res; 2001 Dec 15; 61(24):8611-6. PubMed ID: 11751372
    [Abstract] [Full Text] [Related]

  • 4. Hepatocyte growth factor activator inhibitor 2/placental bikunin (HAI-2/PB) gene is frequently hypermethylated in human hepatocellular carcinoma.
    Fukai K, Yokosuka O, Chiba T, Hirasawa Y, Tada M, Imazeki F, Kataoka H, Saisho H.
    Cancer Res; 2003 Dec 15; 63(24):8674-9. PubMed ID: 14695180
    [Abstract] [Full Text] [Related]

  • 5. Promoter hypermethylation of DNA damage response genes in hepatocellular carcinoma.
    Li Z, Zhang H, Yang J, Hao T, Li S.
    Cell Biol Int; 2012 May 01; 36(5):427-32. PubMed ID: 21864295
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Preoperative serum DNA GSTP1 CpG island hypermethylation and the risk of early prostate-specific antigen recurrence following radical prostatectomy.
    Bastian PJ, Palapattu GS, Lin X, Yegnasubramanian S, Mangold LA, Trock B, Eisenberger MA, Partin AW, Nelson WG.
    Clin Cancer Res; 2005 Jun 01; 11(11):4037-43. PubMed ID: 15930338
    [Abstract] [Full Text] [Related]

  • 9. GSTP1 CpG island hypermethylation is responsible for the absence of GSTP1 expression in human prostate cancer cells.
    Lin X, Tascilar M, Lee WH, Vles WJ, Lee BH, Veeraswamy R, Asgari K, Freije D, van Rees B, Gage WR, Bova GS, Isaacs WB, Brooks JD, DeWeese TL, De Marzo AM, Nelson WG.
    Am J Pathol; 2001 Nov 01; 159(5):1815-26. PubMed ID: 11696442
    [Abstract] [Full Text] [Related]

  • 10. Intensive hypermethylation of the CpG island of Ras association domain family 1A in hepatitis B virus-associated hepatocellular carcinomas.
    Zhong S, Yeo W, Tang MW, Wong N, Lai PB, Johnson PJ.
    Clin Cancer Res; 2003 Aug 15; 9(9):3376-82. PubMed ID: 12960125
    [Abstract] [Full Text] [Related]

  • 11. Methyl-CpG-binding domain protein-2 mediates transcriptional repression associated with hypermethylated GSTP1 CpG islands in MCF-7 breast cancer cells.
    Lin X, Nelson WG.
    Cancer Res; 2003 Jan 15; 63(2):498-504. PubMed ID: 12543808
    [Abstract] [Full Text] [Related]

  • 12. Frequent hypermethylation of CpG islands and loss of expression of the 14-3-3 sigma gene in human hepatocellular carcinoma.
    Iwata N, Yamamoto H, Sasaki S, Itoh F, Suzuki H, Kikuchi T, Kaneto H, Iku S, Ozeki I, Karino Y, Satoh T, Toyota J, Satoh M, Endo T, Imai K.
    Oncogene; 2000 Nov 02; 19(46):5298-302. PubMed ID: 11077447
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Silencing of glutathione S-transferase P1 by promoter hypermethylation and its relationship to environmental chemical carcinogens in hepatocellular carcinoma.
    Zhang YJ, Chen Y, Ahsan H, Lunn RM, Chen SY, Lee PH, Chen CJ, Santella RM.
    Cancer Lett; 2005 Apr 28; 221(2):135-43. PubMed ID: 15808399
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Aberrant CpG island hypermethylation along multistep hepatocarcinogenesis.
    Lee S, Lee HJ, Kim JH, Lee HS, Jang JJ, Kang GH.
    Am J Pathol; 2003 Oct 28; 163(4):1371-8. PubMed ID: 14507645
    [Abstract] [Full Text] [Related]

  • 18. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
    Yuan J, Luo RZ, Fujii S, Wang L, Hu W, Andreeff M, Pan Y, Kadota M, Oshimura M, Sahin AA, Issa JP, Bast RC, Yu Y.
    Cancer Res; 2003 Jul 15; 63(14):4174-80. PubMed ID: 12874023
    [Abstract] [Full Text] [Related]

  • 19. Cytosine methylation represses glutathione S-transferase P1 (GSTP1) gene expression in human prostate cancer cells.
    Singal R, van Wert J, Bashambu M.
    Cancer Res; 2001 Jun 15; 61(12):4820-6. PubMed ID: 11406558
    [Abstract] [Full Text] [Related]

  • 20. Aberrant DNA methylation distinguishes hepatocellular carcinoma associated with HBV and HCV infection and alcohol intake.
    Lambert MP, Paliwal A, Vaissière T, Chemin I, Zoulim F, Tommasino M, Hainaut P, Sylla B, Scoazec JY, Tost J, Herceg Z.
    J Hepatol; 2011 Apr 15; 54(4):705-15. PubMed ID: 21146512
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.